Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Other Non Operating Income (2023 - 2026)

Rallybio's Other Non Operating Income history spans 3 years, with the latest figure at $22.5 million for Q3 2025.

  • On a quarterly basis, Other Non Operating Income rose 8855.78% to $22.5 million in Q3 2025 year-over-year; TTM through Dec 2025 was $22.8 million, a 2960.62% increase, with the full-year FY2025 number at $22.8 million, up 2960.62% from a year prior.
  • Other Non Operating Income hit $22.5 million in Q3 2025 for Rallybio, up from $118000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for RLYB hit a ceiling of $22.5 million in Q3 2025 and a floor of $35000.0 in Q4 2023.
  • Historically, Other Non Operating Income has averaged $2.2 million across 3 years, with a median of $143000.0 in 2024.
  • The widest YoY moves for Other Non Operating Income: up 8855.78% in 2025, down 17.48% in 2025.
  • Tracing RLYB's Other Non Operating Income over 3 years: stood at $35000.0 in 2023, then skyrocketed by 422.86% to $183000.0 in 2024, then surged by 12183.61% to $22.5 million in 2025.
  • Business Quant data shows Other Non Operating Income for RLYB at $22.5 million in Q3 2025, $118000.0 in Q2 2025, and $174000.0 in Q1 2025.